CVE-2024-10476: Default credentials are used in the above listed BD Diagnostic Solutions products. If exploited, threat actors may be able to access, modify or...

8.0 CVSS

Description

Default credentials are used in the above listed BD Diagnostic Solutions products. If exploited, threat actors may be able to access, modify or delete data, including sensitive information such as protected health information (PHI) and personally identifiable information (PII). Exploitation of this vulnerability may allow an attacker to shut down or otherwise impact the availability of the system. Note: BD Synapsys™ Informatics
Solution is only in scope of
this vulnerability when
installed on a NUC server. BD Synapsys™
Informatics Solution installed
on a customer-provided virtual machine or on the BD Kiestra™ SCU hardware is
not in scope.

Classification

CVE ID: CVE-2024-10476

CVSS Base Severity: HIGH

CVSS Base Score: 8.0

Affected Products

Vendor: Becton Dickinson & Co

Product: BD BACTEC™ Blood Culture System

Exploit Prediction Scoring System (EPSS)

EPSS Score: 0.04% (probability of being exploited)

EPSS Percentile: 11.48% (scored less or equal to compared to others)

EPSS Date: 2025-02-04 (when was this score calculated)

References

https://www.bd.com/en-us/about-bd/cybersecurity/bulletin/bd-cybersecurity-vulnerability-bulletin-diagnostic-solutions-products

Timeline